English
A Menu that Matters
By integrating high-quality antibody tests into a routine workflow, laboratories of all sizes can offer physicians a set of tools to gain greater clarity on individuals who have antibodies to SARS-CoV-2 due to prior or recent viral infection.High Sensitivity and Specificity
High sensitivity and specificity are key to providing physicians an accurate picture of patient immune response. Both the Access SARS-CoV-2 IgM and Access SARS-CoV-2 IgG tests have been validated against large, broad-based samples to ensure high quality.Seamless Integration with Routine Lab Workflow
The Access SARS-CoV-2 IgM assay can be seamlessly integrated into current laboratory workflow without the need for batching or special maintenance. This can help your laboratory experience industry-leading system uptime.How else can the Access SARS-CoV-2 IgM assay empower your laboratory to fight the coronavirus pandemic?
- The Access SARS-CoV-2 IgM test throughput on Beckman Coulter immunoassay analyzers and integrated automation systems leads the industry at up to 200 tests per hour depending on the analyzer used (up to 4,800 tests/day)
- QC procedures only need to be run once every 24 hours, or as required by individual laboratory procedure
- Each kit provides 200 tests, which reduces ordering frequency
- REMISOL Advance middleware provides patient results from both diagnostic and serology tests on one screen to help improve laboratory efficiency
